Swept-source microscope-integrated OCT shows promise as training tool
Click Here to Manage Email Alerts
LAS VEGAS — A new intraoperative corneal imaging device, swept-source microscope-integrated OCT, demonstrates new dimensions for real-time intraoperative imaging of the corneal and anterior segment and provides live three-dimensional anatomical information for surgical guidance, according to a speaker here.
“Combining the two [ophthalmic surgical microscope and OCT imaging] gives you microscope integration of OCT technology that allows for intraoperative imaging for surgical guidance,” Terry Kim, MD, said at the Refractive Surgery Subspecialty Day preceding the American Academy of Ophthalmology annual meeting.
Terry Kim
Kim and colleagues at the Duke University Eye Center have created a prototype of a swept-source microscope-integrated OCT (SS-MIOCT) device that attaches to an operating room microscope.
“We have engaged in some early preliminary human studies in patients undergoing cataract and corneal procedures to see the utility of this imaging device,” Kim said, and results are “very encouraging.”
In a study of the impact of microscope-integrated OCT on ophthalmology resident performance of anterior segment maneuvers in model eyes, Kim said, “Feedback-enhanced performance of the trainee surgeons in select depth-based anterior segment maneuvers had no effect on clear cornea wound geometry as performed in this study,” demonstrating promise as a training tool in surgical education of ophthalmology residents. — by Nhu Te
Reference:
Kim T. New Corneal Imaging Devices: Clinical Examples and Applications. Presented at: The Academy of Ophthalmology. Nov. 13, 2015; Las Vegas.
Disclosure: Kim reports he has financial interests with Acuity Advisors, Alcon, Allergan, Bausch + Lomb, CoDa Therapeutics, ForeSight Biotherapeutics, Kala Pharmaceuticals, NovaBay Pharmaceuticals, Ocular Systems, Ocular Therapeutix, Oculeve, Omeros, PowerVision, Presbyopia Therapies, Shire, Stealth BioTherapeutics, TearLab and TearScience.